Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple …

D Cirstea, T Hideshima, S Rodig, L Santo, S Pozzi… - Molecular cancer …, 2010 - AACR
Abstract The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
pathway mediates multiple myeloma (MM) cell proliferation, survival, and development of …
被引用次数：200 相关文章

Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple …

D Cirstea, T Hideshima, S Rodig, L Santo… - Molecular Cancer …, 2010 - hero.epa.gov
Abstract The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
pathway mediates multiple myeloma (MM) cell proliferation, survival, and development of …

Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple …

D Cirstea, T Hideshima, S Rodig… - Molecular cancer …, 2010 - pubmed.ncbi.nlm.nih.gov
The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway
mediates multiple myeloma (MM) cell proliferation, survival, and development of drug …

Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple …

D Cirstea, T Hideshima, S Rodig, L Santo… - Molecular Cancer …, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The phosphoinositide 3-kinase
(PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway mediates multiple myeloma …

Dual inhibition of Akt/Mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple …

D Clrstea, T Hideshima, S Rodig… - Molecular cancer …, 2010 - ohsu.elsevierpure.com
Abstract The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
pathway mediates multiple myeloma (MM) cell proliferation, survival, and development of …

Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple …

D Cirstea, T Hideshima, S Rodig, L Santo… - Molecular Cancer …, 2010 - europepmc.org
Abstract The PI3K/Akt/mTOR pathway mediates multiple myeloma (MM) cell proliferation,
survival, and development of drug resistance, underscoring the role of mTOR inhibitors such …

Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple …

D Cirstea, T Hideshima, S Rodig, L Santo… - MOLECULAR …, 2010 - iris.unimore.it
AbstractThe phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
pathway mediates multiple myeloma (MM) cell proliferation, survival, and development of …
[PDF] psu.edu

[PDF][PDF] Dual Inhibition of Akt/Mammalian Target of Rapamycin

D Cirstea, T Hideshima, S Rodig, L Santo, S Pozzi… - Mol Cancer Ther, 2010 - Citeseer
Abstract The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
pathway mediates multiple myeloma (MM) cell proliferation, survival, and development of …

[引用][C] Dual inhibition of Akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple …

D CIRSTEA - Mol Cancer Ther, 2010 - cir.nii.ac.jp
Dual inhibition of Akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin
and perifosine induces antitumor activity in multiple myeloma | CiNii Research CiNii 国立 …
[PDF] psu.edu

[PDF][PDF] Dual Inhibition of Akt/Mammalian Target of Rapamycin

D Cirstea, T Hideshima, S Rodig, L Santo, S Pozzi… - Mol Cancer Ther, 2010 - Citeseer
Abstract The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
pathway mediates multiple myeloma (MM) cell proliferation, survival, and development of …